Tagged: ip
- Nº 08Essay
The Antibody That Half the Market Rents
Five diagnostics platforms are racing toward Alzheimer's blood testing. Two licensed the same antibody from the same small biotech. A third group hasn't entered the avenue at all.
Strategic thinking on in-vitro diagnostics — calibrating the conversation between East and West, from the Mexican bench.
Five diagnostics platforms are racing toward Alzheimer's blood testing. Two licensed the same antibody from the same small biotech. A third group hasn't entered the avenue at all.
Newsletter
Selected essays on the strategy of in-vitro diagnostics, delivered to your inbox every two weeks.
Free. No spam. We never share your email with third parties. Unsubscribe anytime.